Arcturus Therapeutics Holdings Inc
Arcturus Therapeutics Holdings Inc (ARCT) Option Chain
Read more
Tracking the ARCT option chain helps you see every strike and expiry on Arcturus Therapeutics Holdings Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ARCT options activity at a glance. Use our scanner to monitor the ARCT option chain in real time and filter for the trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ARCT stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where ARCT options are being actively traded, and where they are not.
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lung disease caused by mutations in cystic fibrosis transmembrane conductance regulator (CFTR) gene, as well as vaccine programs include LUNAR-COV19 and LUNAR-FLU. It has collaboration partnerships with Vinbiocare Biotechnology Joint Stock Company for the manufacture of COVID-19 vaccines; Janssen Pharmaceuticals, Inc.
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 4.50 | 0 | 0 | 0.39 | 2.31 | 0.50 | 4.90 | 6.00 | -28.23 | — | 1.75 | 0.00 | 1.75 | 0 | 0 | 95.50 |
| 31.03 | 0 | 0 | 1.69 | 0.81 | 0.10 | 4.90 | 7.50 | -10.29 | — | 0.70 | 0.00 | 0.70 | 0 | 0 | 68.97 |
| 68.64 | 1 | 0 | 0.85 | 0.00 | — | 0.85 | 9.00 | +7.66 | 0.70 | 1.10 | 0.69 | 0.21 | 0 | 71 | 31.36 |
| 85.37 | 251 | 1 | 0.20 | 0.00 | — | 0.20 | 10.00 | +19.62 | — | 2.00 | 1.69 | 0.31 | 0 | 140 | 14.63 |
| 94.12 | 175 | 0 | 1.45 | 0.00 | — | 1.45 | 11.00 | +31.58 | 1.75 | 3.40 | 2.69 | -0.11 | 0 | 7 | 5.88 |
As of Nov 16, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV Rank93.25% High
- Market cap (M$)240
- 52 weeks high-53.73%
- 52 weeks low51.09%
- Analyst recommendationStrong Buy
1.31 - Target price$23.70
185.20% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-05
- P/E—
- Future P/E—
- EPS (ttm)-3.08
- EPS growth next 5 years-11.55%
As of Nov 16, 2026